Email Updates

You are here

Home

7 FEBRUARY 2020 VOLUME 21 ISSUE 5

Media Coverage

  • PrEP in Pregnancy: Safe, but Many Unanswered Questions

    Unanswered questions about the safety of taking PrEP during pregnancy and breastfeeding should not be allowed to stand in the way of access to PrEP for women who need it at these times, a systematic review published in the Journal of the International AIDS Society concludes.

    February 7, 2020
    PrEP
    aidsmap

  • Your PrEP Is Not a Status Symbol

    The introduction of Descovy into the country’s HIV prevention efforts is a big deal—we now have multiple options for PrEP for the first time. But from my position as a public health worker and HIV educator, I’ve begun to observe a disturbing trend in the way gay and bisexual male communities are talking about this exciting shift.

    February 6, 2020
    PrEP
    Slate

  • Progress and Stumbles One Year Into Trump’s Plan to End HIV

    A year ago, President Trump announced a groundbreaking initiative to end HIV transmission in the United States by 2030.

    February 6, 2020
    General
    The Hill

  • What the Discovery of a New HIV Strain Means for the Pandemic

    The discovery of a rare new strain of HIV for the first time in nearly 20 years recently made headlines around the world. The big question is what the discovery means for the overall response to the HIV epidemic.

    February 6, 2020
    General
    The Conversation

  • Every Stigma That’s Old Is New Again: The Coronavirus, HIV, and Junk Science

    It’s the early, panic-inducing days of a new virus. People who may have been exposed are quarantined. Americans are being asked to keep their distance from others, just in case someone has been exposed to the virus and doesn’t show signs of infection yet. There are scary reports of deaths from the virus, and uncertainty about how it spreads—and so, just to be safe, people are buying masks.

    February 6, 2020
    General
    The Body

  • Why We’re Still Optimistic Even in Disappointment About an HIV Vaccine

    An HIV vaccine remains what South Africa and the world needs to prevent new HIV infections. This is in addition to a range of other HIV prevention tools that are available and in the pipeline. However, one of the HIV vaccine research studies, Uhambo (HVTN 702), has been stopped early because it was determined by an independent review body that it did not show a possibility to prevent HIV. This, for a moment, came as disappointing news; however, as South Africans we realise the search for a safe and effective HIV vaccine has to continue.

    February 6, 2020
    HIV Vaccine
    Daily Maverick

  • Government Plans Massive PrEP Rollout

    The Department of Health aims to make a pill to prevent HIV infection available at all community health centres and primary healthcare clinics in South Africa by the end of September this year.

    February 5, 2020
    PrEP
    Spotlight

  • Gilead Loses Its Challenge to a Pair of US Patents for an HIV Prevention Pill

    In a setback to Gilead Sciences (GILD), a federal panel rejected its bid to invalidate a pair of patents owned by the US government for using the Truvada pill to prevent HIV, a drug that has sparked controversy due to its cost and the extent to which taxpayer dollars funded crucial research.

    February 5, 2020
    PrEP
    STAT News

  • Black Women HIV Rates Decline, But Is It Progress?

    Earlier this year, the Centers for Diseases Control and Prevention’s Morbidity and Mortality Weekly Report revealed that Black women accounted for 60 percent of all new HIV diagnoses in women in the United States — despite the fact that they only make up 13 percent of the population.

    February 5, 2020
    HIV Plus Mag

  • PEPFAR Seeks Coordination With Other Aid Donors, Says US AIDS Chief

    Ambassador Deborah Birx, the US global AIDS coordinator, says she is not worried about the Trump administration’s repeated proposals to slash her budget, but that is not stopping her from looking for other sources of funding wherever she can find them.

    February 5, 2020
    General
    Devex

  • Another HIV Vaccine Fails a Trial, Disappointing Researchers

    In another setback in the long quest to prevent HIV infection, a trial in South Africa has been shut down because an experimental vaccine was not working, federal health officials announced on Monday.

    February 4, 2020
    HIV Vaccine
    New York Times

  • Trump Promised to Eradicate HIV at Last Year’s SOTU. So Far, His Results Are Meh

    At last year’s State of the Union Address, President Donald Trump pledged to end the spread of HIV in the United States by 2030. A year later, his chances of success are still TBD.

    February 4, 2020
    General
    Mother Jones

  • Another HIV Vaccine Strategy Fails in Large-scale Study

    The HIV vaccine that had moved furthest along in human testing does not work, and the $104 million trial in South Africa evaluating it has been stopped early.

    February 3, 2020
    HIV Vaccine
    Science

  • Quest for HIV Vaccine Continues After Latest Trial Fails

    US health authorities said Monday they were halting a trial in South Africa of an experimental HIV vaccine after it proved ineffective at preventing the infection.

    February 3, 2020
    HIV Vaccine
    Daily Nation

Published Research

Announcements